100 related articles for article (PubMed ID: 3486262)
1. [Cellular immunity in nasopharyngeal carcinoma cases].
Tsukuda M; Tamamushi N; Mochimatsu I; Mitarai K; Sawaki S
Nihon Jibiinkoka Gakkai Kaiho; 1986 Jan; 89(1):7-13. PubMed ID: 3486262
[No Abstract] [Full Text] [Related]
2. Cellular immunity in nasopharyngeal carcinoma. III. Lymphocyte subpopulations and lymphocyte response to phytohemagglutinin.
Hsu MM; Wang KR; Lynn TC; Hsieh T; Tu SM
Taiwan Yi Xue Hui Za Zhi; 1978 Jul; 77(7):549-55. PubMed ID: 308994
[No Abstract] [Full Text] [Related]
3. Immunologic reactivity in patients with nasopharyngeal carcinoma.
Hsu MM; Wang KR; Lynn TC; Hsieh T; Huang SC; Tu SM
Otolaryngol Head Neck Surg; 1980; 88(4):384-90. PubMed ID: 6821420
[TBL] [Abstract][Full Text] [Related]
4. Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma.
Chan SH; Chew TS; Goh EH; Simons MJ; Shanmugaratnam K
Int J Cancer; 1976 Aug; 18(2):139-44. PubMed ID: 955740
[TBL] [Abstract][Full Text] [Related]
5. Impaired long-term T cell immunity to Epstein-Barr virus in patients with nasopharyngeal carcinoma.
Tamura S; Yamazaki A; Kunimoto M; Takemura K; Tabata T; Hinuma Y; Yoshie O
Jpn J Cancer Res; 1992 May; 83(5):445-9. PubMed ID: 1319984
[TBL] [Abstract][Full Text] [Related]
6. [Lymphocyte proliferation assay of the tumor associated antigen derived from a nasopharyngeal carcinoma cell line (NPC-204)].
Tsukuda M
Nihon Jibiinkoka Gakkai Kaiho; 1982 Aug; 85(8):963-70. PubMed ID: 7143149
[No Abstract] [Full Text] [Related]
7. Enumeration of lymphocyte subsets before and after concanavalin A stimulation by using flow cytometry in patients with nasopharyngeal carcinoma.
Hsu MM; Hsu LW; Yang PM
Taiwan Yi Xue Hui Za Zhi; 1987 Jul; 86(7):712-7. PubMed ID: 3500269
[No Abstract] [Full Text] [Related]
8. [Immunobiology of cancer].
Oettgen HF
Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1973; 205(1):21-36. PubMed ID: 4349192
[No Abstract] [Full Text] [Related]
9. Response of lymphocyte subpopulations to phytohemagglutinin, concanavalin A and pokeweed mitogen in patients with nasopharyngeal carcinoma.
Hsu MM; Lin BL
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Nov; 18(4):224-31. PubMed ID: 3878769
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of serum neopterin levels in patients with nasopharyngeal carcinoma and its significance].
Wang L; Jin S; Wei Q; Xiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 May; 15(5):204-5. PubMed ID: 12541762
[TBL] [Abstract][Full Text] [Related]
11. [Cell-mediated immune function in NPC patients treated with cimetidine].
Zeng P; Xiao J; Lei Y
Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):223-5. PubMed ID: 7656832
[TBL] [Abstract][Full Text] [Related]
12. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
[No Abstract] [Full Text] [Related]
13. Activated T lymphocytes in infiltrates and draining lymph nodes of nasopharyngeal carcinoma.
Galili U; Klein E; Klein G; Singh Bal I
Int J Cancer; 1980 Jan; 25(1):85-9. PubMed ID: 6249765
[TBL] [Abstract][Full Text] [Related]
14. Association between nasopharyngeal carcinoma and HLA antigens in Greeks.
Zervas J; Gregoriadis S; Tourlas D; Varlegidis E; Pantazopoulos P
Panminerva Med; 1983; 25(4):255-7. PubMed ID: 6584851
[No Abstract] [Full Text] [Related]
15. Cell-mediated immunity, Epstein-Barr virus and nasopharyngeal carcinoma.
Levine PH; Lamelin JP; Stevens DA
IARC Sci Publ (1971); 1978; (20):483-94. PubMed ID: 215530
[TBL] [Abstract][Full Text] [Related]
16. Elevated IGA in carcinoma of the nasopharynx.
Wara WM; Wara DW; Phillips TL; Ammann AJ
Cancer; 1975 May; 35(5):1313-5. PubMed ID: 1122483
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity to Epstein-Barr virus in nasopharyngeal carcinoma.
Cahn SH; Chew TS; Kunaratnam N
Lancet; 1979 Apr; 1(8121):884-5. PubMed ID: 86139
[No Abstract] [Full Text] [Related]
18. Suppressed cellular immunity in patients with nasopharyngeal carcinoma.
Tsukuda M; Sawaki S; Yanoma S
J Cancer Res Clin Oncol; 1993; 120(1-2):115-8. PubMed ID: 8270600
[TBL] [Abstract][Full Text] [Related]
19. [Influence of HPD on immunological functions in patients with nasopharyngeal carcinoma treated by radiotherapy].
Xia Y; Zhang E; Hu Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(3):168-70. PubMed ID: 9639718
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal carcinoma membrane soluble antigen.
Tsukuda M; Sawaki S; Yanoma S; Yoshimura N; Takei M; Takada M; Sudo K; Suzuki K; Kawamura A
Jpn J Exp Med; 1980 Feb; 50(1):79-84. PubMed ID: 6155484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
